PMV PHARMACEUTICALS INC. - COMMON STOCK

PMV Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights

13 Aug 2021 08:00:00 By Nasdaq GlobeNewswire

PMV Pharmaceuticals Announces Participation at the Bank of America Securities 2021 Napa Biopharma Virtual Conference

09 Jun 2021 08:00:01 By Nasdaq GlobeNewswire

PMV Pharmaceuticals Announces Participation at the Goldman Sachs Annual Healthcare Conference

03 Jun 2021 08:00:01 By Nasdaq GlobeNewswire

PMV Pharmaceuticals Announces Participation at the Bank of America Healthcare Conference

05 May 2021 08:00:02 By Nasdaq GlobeNewswire

PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer Research Annual Meeting 2021

10 Apr 2021 13:31:00 By Nasdaq GlobeNewswire

PMV Pharma Strengthens Board of Directors with Appointment of Dr. Charles Baum

06 Apr 2021 08:00:01 By Nasdaq GlobeNewswire

PMV Pharmaceuticals Announces Presentation of PC14586 Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2021

10 Mar 2021 16:31:00 By Nasdaq GlobeNewswire

PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights

03 Mar 2021 16:01:00 By Nasdaq GlobeNewswire

PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference

23 Feb 2021 08:00:01 By Nasdaq GlobeNewswire

PMV Pharma Appoints p53 Pioneer Dr. Guillermina Lozano to Scientific Advisory Board

16 Feb 2021 08:00:05 By Nasdaq GlobeNewswire